CATHERINE WALKER: Open Payments
NPI 1255749560 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$829 in 29 payments from 8 companies in 2025. Trend: 2023 $1,837 · 2024 $1,496 · 2025 $829
Food & beverage: $829
| Company | Payments | Amount |
|---|---|---|
| Caris MPI, Inc. | 7 | $196 |
| Eisai Inc. | 6 | $184 |
| GlaxoSmithKline, LLC. | 4 | $112 |
| ABBVIE INC. | 3 | $104 |
| Merck Sharp & Dohme LLC | 3 | $94 |
| AstraZeneca Pharmaceuticals LP | 4 | $86 |
| Verastem, Inc. | 1 | $35 |
| Astellas Pharma US Inc | 1 | $19 |
Products named: MI CANCER SEEK, Lenvima, LYNPARZA, ELAHERE, JEMPERLI, KEYTRUDA QLEX, AVMAPKI FAKZYNJA CO-PACK, KEYTRUDA.
Industry payments across TN — which companies pay providers there.
